BMRN
NASDAQ
$59.11
Biomarin Pharmaceutical Inc (BMRN)
BioMarin Pharmaceutical Inc. develops and markets therapies for people with rare diseases and serious and life-threatening medical conditions. The company is headquartered in San Rafael, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $87.96 (+48.81%)
Market Cap
$11B
PEG Ratio
0.73
FCF 5Y CAGR
+46.21%
Forward P/E
11.96
Price Chart
Valuation
Market Cap$11B
P/E42.21
Forward P/E11.96
PEG0.73
P/S3.50
P/B1.84
Profitability
Total Revenue (TTM)$3.24B
Gross Profit (TTM)$1.66B
EBITDA$389M
Profit Margin13.8%
Operating Margin16.9%
EPS$1.40
Financial Health
Debt-to-Equity23%
Free Cash Flow Yield6.73%
Growth & Risk
EPS 5Y CAGR-20.33%
Revenue 5Y CAGR+11.94%
FCF 5Y CAGR+46.21%
Beta (5Y)0.65
Sharpe Ratio0.09